Copper Peptide GHK-Cu vs LL-37

Overview

Copper Peptide GHK-Cu is primarily a cosmetic & skin peptide, while LL-37 is used for immune support.

This page compares Copper Peptide GHK-Cu and LL-37 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Copper Peptide GHK-Cu is categorised under Cosmetic & Skin, while LL-37 falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Copper Peptide GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026. LL-37: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Copper Peptide GHK-Cu is typically dosed at Topical or injectable (daily). LL-37 is typically dosed at 2-5 mg (twice weekly).

Can you stack them?

Some protocols combine peptides, but stacking Copper Peptide GHK-Cu and LL-37 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Copper Peptide GHK-Cu and LL-37?

Copper Peptide GHK-Cu is primarily a cosmetic & skin peptide, while LL-37 is used for immune support. Copper Peptide GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas LL-37 is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is Copper Peptide GHK-Cu used for?

Multi-functional skin peptide.

What is LL-37 used for?

Antimicrobial defense peptide.

Can you take Copper Peptide GHK-Cu and LL-37 together?

Some users combine peptides within a single protocol, but stacking Copper Peptide GHK-Cu and LL-37 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Copper Peptide GHK-Cu or LL-37 FDA-approved?

Copper Peptide GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026). LL-37 is not FDA-approved; compounding permitted with a prescription (as of April 2026).